COVID-19 virus evolved quickly but within strict genetic limits

A new paper in Genome Biology and Evolution, published by Oxford University Press, indicates that while the COVID-19 virus has developed rapidly since 2019, it has done so within limited genetic channels. These genetic limits have remained unchanged. Despite scientists' earlier fears about dramatic, rapid evolution of the COVID-19 virus, it appears recent changes in the virus were relatively constrained; the virus altered by combining pre-existing mutations. The virus has not expanded the number of genetic routes it can take to evolve.

SARS-CoV-2 underwent rapid evolution after first infecting humans in late 2019, resulting in new viral variants with properties that made them successful in human hosts. Previous work has shown how these variants were not closely related to the major circulating variants that preceded them, which led many scientists to believe that changes to the spike protein structure (the spikes or "crown" portion of the familiar COVID-19 microscopic image) drove SARS-CoV-2 variant evolution, enabling new mutations which had previously been impossible for the virus.

The SARS-CoV-2 pandemic was the worst pandemic of an infectious disease in recent decades, causing global mortality, economic damage, and social disruption. However, the response to the pandemic using contemporary technologies like affordable mass sequencing has resulted in a unique and significant scientific dataset.

Researchers here took advantage of the scale of global genome sequencing, protein structural determination, and targeted studies related to the virus. They used rich SARS-CoV-2 datasets to investigate the role of protein structural constraint in SARS-CoV-2 evolution and whether changes to spike protein structure made the virus stronger. They applied multiple computational predictors of structural constraint across different structural backgrounds and assessed how constraint has changed during SARS-CoV-2 variant evolution.

The investigation found that SARS-CoV-2 has undergone several distinct phases of evolution. An initial period of neutral diversification ended in late 2020 when multi-mutant variants began to arise. The World Health Organization classified variants with suspected phenotypic characteristics, such as increased transmissibility or immune escape properties, as variants of concern. But despite the unprecedentedly rich and granular dataset, the investigators find no evidence that structural constraints have changed substantially or played a role in SARS-CoV-2 S protein variant evolution. Despite high mutation rates and strong selective pressure, the SARS-CoV-2 S protein was under strong structural constraints after moving to human hosts.

It appears that while SARS-CoV-2 evolved rapidly during the pandemic, there were no substantial changes in the set of structurally viable mutations. The findings suggest that variant emergence came not from relaxation of structural constraints but by novel combinations of mutations with functional genetic interactions. But overall evolution remained tightly constrained by spike protein stability.

Our research explores the dynamics of evolutionary change in SARS-CoV-2 in the period following its spillover into the human population. We found that strong constraints acting on the virus' spike protein limited what mutations could occur. This helps us understand how other coronaviruses might behave when they jump between species and could have important implications for the design of future vaccines and antiviral drugs."

James Herzig, paper's lead author

Source:
Journal reference:

Herzig, H. C., et al. (2026) Structural Constraints Acting on the SARS-CoV-2 Spike Protein Reveal Limited Space for Viral Adaptation. Genome Biology and Evolution. DOI: 10.1093/gbe/evag049. https://academic.oup.com/gbe/article/doi/10.1093/gbe/evag049/8512735

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Online tool helps cancer patients share genetic risk with families